Results 61 to 70 of about 1,488,693 (165)

Analysis of the drug target of the anti-tuberculosis compound OCT313: phosphotransacetylase is a potential drug target for anti-mycobacterial agents. [PDF]

mSphere
Takii T, Hasegawa T, Itoh S, Maeda S, Wada T, Horita Y, Nishiyama A, Matsumoto S, Ohara N, Kimishima A, Asami Y, Hida S, Onozaki K.   +12 more
europepmc   +1 more source

Commentary on "Neg-entropy is the true drug target for chronic diseases". [PDF]

Acta Pharm Sin B
Coker O, Yu J.
europepmc   +1 more source

Genomics of drug target prioritization for complex diseases. [PDF]

Nat Rev Genet
Chen R, Duffy Á, Do R.
europepmc   +1 more source

Proteome-Guided Drug Target Discovery for Periodontitis. [PDF]

J Clin Periodontol
Alayash Z, Baumeister SE, Holtfreter B, Kocher T, Baurecht H, Ehmke B, Hagenfeld D, Reckelkamm SL, Nolde M.   +8 more
europepmc   +1 more source

KANPM-DTA: improving drug-target affinity prediction with Kolmogorov-Arnold networks and pretrained models. [PDF]

Brief Bioinform
Rakib MDYK, Alamin MH, Li J, Mamun SS, Gobena KA, Ren S.   +5 more
europepmc   +1 more source

Curation of the Fasciola hepatica kinome as a resource for drug target discovery. [PDF]

BMC Genomics
Ajmera S, Puckelwaldt O, Stroehlein AJ, Haeberlein S.   +3 more
europepmc   +1 more source

Genetic Association of Lipids and Lipid-Lowering Drug Target Genes With Atopic Dermatitis: A Drug Target Mendelian Randomization Study. [PDF]

Health Sci Rep
Luo M, Lin J, Zhuo Q, Lin L, Han Y.
europepmc   +1 more source

Neg-entropy is the true drug target for chronic diseases. [PDF]

Acta Pharm Sin B
Li R, Gao TL, Ren G, Wang LL, Jiang JD.
europepmc   +1 more source

Role of IL-32 in RA pathology and potential as a drug target. [PDF]

Front Immunol
Zhang H, Chen Q, Yu H, Zhu M, Zhang X, Fu X, Wu S, Wang G.   +7 more
europepmc   +1 more source

MGF-DTA: A Multi-Granularity Fusion Model for Drug-Target Binding Affinity Prediction. [PDF]

Int J Mol Sci
Ni Z, Wei B, Zeng Y.
europepmc   +1 more source